Literature DB >> 4118423

Interstitial pneumonitis associated with bleomycin therapy.

M A Luna, C W Bedrossian, B Lichtiger, P A Salem.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4118423     DOI: 10.1093/ajcp/58.5.501

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  28 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  Fatal pneumothorax associated with bleomycin-induced pulmonary fibrosis.

Authors:  D C Doll
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Bronchoalveolar lavage cell populations in bleomycin lung toxicity.

Authors:  D A White; M G Kris; D E Stover
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

Review 4.  Lung damage from cytotoxic drugs.

Authors:  C H Collis
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 5.  Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review.

Authors:  A L Katzenstein; C M Bloor; A A Leibow
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

6.  Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis.

Authors:  E Fasske; K Morgenroth
Journal:  Lung       Date:  1983       Impact factor: 2.584

7.  Complications after combination of chemotherapy and radiation for malignant brain tumours.

Authors:  R Dietz; L Burger; K Schimrigk; K H Merkel
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

8.  Inhibition of bleomycin-induced pulmonary fibrosis by cobra venom factor.

Authors:  S H Phan; R S Thrall
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

9.  Inhibition of transforming growth factor-beta signalling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice.

Authors:  S Segawa; D Goto; Y Yoshiga; M Sugihara; T Hayashi; Y Chino; I Matsumoto; S Ito; T Sumida
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

10.  Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis.

Authors:  J M Kaufman; C A Cuvelier; M Van der Straeten
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.